• Oncology Clinical Trials

Your oncology discovery deserves an innovative approach

 

Specialized solutions to accelerate your breakthrough

Let's Talk

Every year across the globe, cancer affects the quality of life for millions of people. The far-reaching impact of cancer and demand for treatments that improve duration and outcomes for patients inspires a race for biotech companies to develop new therapeutics.

However, with complex oncology trials and the many unknowns that come with next generation therapies, there are endless hurdles. Your scientific discoveries deserve an innovative approach to clinical development.

Streamlined clinical development approaches, coupled with effective CRO-sponsor partnerships, not only result in success for emerging biopharma companies, but can also generate tremendous value for patients. As a full-service oncology CRO, we are dedicated to supporting biotech and emerging biopharma companies through every phase of development. Our extensive oncology expertise coupled with an end-to-end approach helps accelerate your clinical programs, giving you confidence to bring breakthrough treatments to patients.

I am delighted to work alongside biotech sponsors in the exciting world of oncology drug development. We experience the highs and lows with our customers, and nothing is more rewarding than helping a customer successfully bring a new treatment to patients.

Gerhard du Toit, GLOBAL HEAD, ONCOLOGY
We’re dedicated to providing flexible end-to-end oncology solutions, from lab discovery to clinical delivery, to maximize value to both sponsors and patients.
Erin Finot, Vice President, Immuno-Oncology & CAGT

Cancer affects us all in one way or another. We're committed to help innovative biotechs leverage advanced data and build patient centered trial strategies to bring novel treatments to the patients who need them.

Matt Simmons, Senior Director, Oncology Strategy

Oncology clinical trial expertise

Our strong foundation of therapeutic, scientific, and operational expertise enables us to bring unparalleled innovation to oncology clinical development, making your trial more precise, predictable and efficient.

  • 500+ studies in the past 5 years 
  • Experience working in more than 50 countries 
  • 16 FDA approved oncology therapies
  • Board-certified oncologists and hematologists on staff
  • Global oncology key opinion leaders and site networks
  • Global oncology regulatory expertise 
EARLY PHASE ONCOLOGY

Our extensive early phase oncology experience enables us to guide your program through the intricacies inherent in dose-finding and dose-optimization, safety and proof-of-concept studies in a sick patient population. We look beyond first-in-human, and are active in a range of adaptive, basket and umbrella designs, as well as complex multi-arm platform design trials.

  • Global network of specialist Phase I oncology sites
  • Technology solutions for enhanced cohort planning and management
  • Modeling and simulation of multiple datasets to identify optimal dose of novel targeted and immune therapies
  • Laboratory services from Q2 Solutions for biomarker services, assay validation and development of companion diagnostics
LATE PHASE ONCOLOGY

We offer modern solutions for patient-focused trials that accelerate enrollment, reduce site burden, and deliver trials on time and budget.

  • Proven decentralized trial solutions
  • Global network of trial sites to optimize patient recruitment
  • Precision site selection, centralized monitoring, and automated safety case processing
  • Global regulatory expertise
Experience by phase

Early and late phase expertise

IQVIA Biotech has staff with specific early phase and late phase experience to address the nuances of different phases of development and can grow with you as your pipeline matures.

ONCOLOGY INSIGHTS

Fact sheet
IQVIA's Experience and Expertise in Radiopharmaceutical Clinical Trials
Learn more
Article
Accelerate Development of New Oncology Therapies with FDA's Project FrontRunner
Learn more
Blog
From Innovation to Collaboration: How Project Optimus is Influencing Emerging Biopharma and Biotech
Learn more
Publication
Diving deeper into understanding patient care implications of growing oncology R&D advances: notable takeaways from ESMO and ASH 2023
Learn more
White paper
Radiation Therapy Quality Assurance in Clinical Trials
learn more
Blog
Top 5 Challenges for Pursuing IO Therapy Clinical Trials
learn more
White Paper
Planning for High-Performance Hematologic Oncology Clinical Trials
Learn more
Blog
Diversity and inclusion in oncology clinical trials
learn more
Insight Briefs
Navigating the Complex Oncology Landscape
New strategies for clinical trial success
Learn more
Blog
IQVIA’s EPON Paves the Way for More Efficient Early Phase Oncology Research
Learn more
Blog
A caregiver’s perspective on turning sorrow into progress
Learn more
White Paper
Excellence in Immuno-Oncology Clinical Trials
Plan for success and reduce risk when developing novel treatments for patients with cancer
learn more
Article
Cell and Gene R&D in Cancer Care: Increasing Patient Access
Learn more
Article
Better Balance of Cancer Treatment Efficacy and Toxicity
Learn more
Insight Brief
The Shifting Paradigm of Dose Selection in Oncology
Moving from drug-centered to patient-centered drug development
Learn more
Discussion Brief
Advancing Pediatric Cancer Research
Impact and Implications for the RACE for Children's Act
Learn More

Our experienced oncology teams are here to support your clinical trial in any indication

  • Bladder
  • Breast
  • Cervical
  • Colorectal
  • Dermatologic oncology
  • Gastroesophageal junction
  • Glioblastoma multiforme
  • Gynecological
  • Head and neck
 
  • Hematologic malignancies
  • Kidney 
  • Leukemia
  • Liver 
  • Lymphoma
  • Lung 
  • Melanoma
  • Mesothelioma
  • Multiple myeloma
 
  • Myelodysplastic syndrome
  • Neuro 
  • Ovarian
  • Pancreatic
  • Prostate 
  • Renal 
  • Soft tissue sarcoma 
  • Solid tumor
  • Supportive care
 
SOLUTION

IQVIA Oncology COE

By making intelligent connections, we bring innovation to the needs of today’s oncology development to help you focus on the patient, manage trial complexity, and increase predictability and speed.
Learn more

Connected Intelligence for oncology clinical development

Our powerful approach brings together oncology experts, data-driven insights, global site networks, and innovative technologies to help you drive smarter decisions to accelerate clinical development.

Learn More
Related Solutions
Real World Evidence

Generate and disseminate the right real world evidence (RWE) to meet stakeholder needs with confidence.

Rare Disease Expertise

Build on our experience of more than 300 rare disease studies to fulfill your promise of hope to millions around the world.

Global Oncology Intelligence

Unravel the complexities of cancer treatment with patient-level data-driven solutions.

IQVIA Biotech's Oncology Resource Center

Explore Insights & Resources Library
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Email Us
Contact Us